.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Mupirocin - Generic Drug Details

« Back to Dashboard
Mupirocin is the generic ingredient in three branded drugs marketed by Perrigo New York, Taro, Glenmark Pharms, Teva, Glaxosmithkline, Fougera Pharms, and Glenmark Generics, and is included in ten NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

This ingredient has five patent family members in five countries.

There are twelve drug master file entries for mupirocin. Twenty-eight suppliers are listed for this compound.

Summary for Generic Name: mupirocin

Tradenames:3
Patents:1
Applicants:7
NDAs:10
Drug Master File Entries: see list12
Suppliers / Packaging: see list28
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Drug Prices:see low prices

Pharmacology for Ingredient: mupirocin

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline
BACTROBAN
mupirocin
OINTMENT;TOPICAL050591-001Dec 31, 1987RXYes► subscribe► subscribe
Taro
MUPIROCIN
mupirocin
OINTMENT;TOPICAL065170-001Sep 23, 2005RXNo► subscribe► subscribe
Glenmark Pharms
MUPIROCIN
mupirocin
OINTMENT;TOPICAL090480-001Jun 8, 2011RXNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: mupirocin

Country Document Number Estimated Expiration
Spain2165723► subscribe
European Patent Office0933081► subscribe
Israel123143► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc